Advertisement

Linguistic Validation of the French Canadian Work Productivity and Activity Impairment Questionnaire–General Health Version

  • Mary Gawlicki
  • Shawn McKown
  • Matthew Talbert
  • Barbara Brandt
  • Eric Bullington
Global Topics

Abstract

Objectives

The objective of this study was to evaluate the linguistic validity of the French Canadian Work Productivity and Activity Impairment–General Health questionnaire (WPAI-GH). When ill, employees may take a sick day (absenteeism) or work despite the illness and experience a loss of efficiency (presenteeism), which may then result in organizational productivity loss. The WPAI-GH, a leading measure of work productivity indicators, was not previously tested among French Canadians for clarity of translation and item comprehension. Before using a French translation of an available US-English questionnaire, the linguistic validity must be established to ensure its conceptual equivalence to the original as well as establishing cultural appropriateness.

Methods

A French Canadian translation of the US-English WPAI-GH was produced through a reiterative process in which harmonized forward and back translations were created by independent translators. French-speaking subjects residing in Canada self-administered the WPAI-GH and were subsequently debriefed by a bilingual (French-English) interviewer.

Results

Thirty French Canadian subjects were interviewed, all of whom were employed at the time. The group was stratified by educational level, including an equal number of participants with and without a high school degree. Responses to hypothetical scenarios indicated that the French Canadian version adequately differentiates between sick time taken for health and non-health reasons as well as differentiations between absenteeism and presenteeism.

Conclusion

The linguistic validity of the French Canadian translation of the WPAI-GH was established among a diverse French Canadian population, including those with minimal education.

Keywords

Work Productivity and Activity Impairment Questionnaire–General Health Version (WPAI-GH) absenteeism presenteeism occupational health translation cognitive debriefing linguistic validation patient-reported outcomes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Prasad M, Shih YCT, Wahlqvist P, Shikiar R. A critical review of health-related productivity measures. Value in Health. 2002;5: A535–A536.CrossRefGoogle Scholar
  2. 2.
    Durand MJ, Vachon B, Hong QN, Imbeau D, Amick BC, Loisel P. The cross-cultural adaptation of the Work Role Functioning Questionnaire in Canadian French. Int J Rehabil Res. 2004;27(4):261–268.CrossRefGoogle Scholar
  3. 3.
    Dionne CE. Psychological distress confirmed as predictor of long-term back-related functional limitations in primary care settings. J Clin Epideimiol. 2005;58(7):714–718.CrossRefGoogle Scholar
  4. 4.
    Fautrel B, Hilliquin P, Rozenberg S, et al. Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA. Joint Bone Spine. 2005;72(3):235–240.CrossRefGoogle Scholar
  5. 5.
    The CIA world factbook. North America: Canada. https://doi.org/www.cia.gov/library/publications/the-world-factbook/geos/ca.html. Accessed February 16, 2010.
  6. 6.
    Statistics Canada. https://doi.org/www.statcan.gc.ca/start-debut-eng.html. Accessed February 16, 2010.
  7. 7.
    Reilly Margaret C. Development of the Work Productivity and Activity Impairment (WPAI) Questionnaire. New York, NY: Reilly Associates; 2008.Google Scholar
  8. 8.
    United North America. Similarities & differences between Canada & the United States. https://doi.org/www.unitednorthamerica.org/simdiff.htm. Accessed February 16, 2010.
  9. 9.
    Centers for Disease Control and Prevention. National Health Interview Survey. https://doi.org/www.cdc.gov/nchs/nhis/jcush.htm. Accessed February 16, 2010.
  10. 10.
    Cull A, Sprangers M, Bjordal K, Aaronson N, West K, Bottomley A. EORTC Quality of Life Group Translation Procedure. 2nd ed. Brussels: EORTC; 2002.Google Scholar
  11. 11.
    Carlson ED. A case study in translation methodology using the Health-Promotion Lifestyle Profile II. Public Health Nurs. 2000;17(1):61–70.CrossRefGoogle Scholar
  12. 12.
    Mathias SD, Fifer SK, Patrick DL. Rapid translation of quality of life measures for international clinical trials: avoiding errors in the minimalist approach. Qual Life Res. 1994;3(6):403–12.CrossRefGoogle Scholar
  13. 13.
    Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value in Health. 2005;8(2):94–104.CrossRefGoogle Scholar
  14. 14.
    Gauthier AP, Lariviere M, Young N. Psychometric properties of the IPAQ: a validation study in a sample of northern Franco-Ontarians. J Phys Act Health. 2009;6(suppl 1): S54–S60.CrossRefGoogle Scholar
  15. 15.
    Karakiewicz PI, Perrotte P, Valiquette L, et al. French-Canadian linguistic validation of the NIH Chronic Prostatitis Symptom Index. Can J Urol. 2005;12(5):2816–2823.PubMedGoogle Scholar
  16. 16.
    Deslauriers V, Rouleau DM, Alami G, MacDermid JC. Translation of the Patient Scar Assessment Scale (PSAS) to French with cross-cultural adaptation, reliability evaluation and validation. Can J Surg. 2009;52(6): E259–E263.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Hunt E, Vachon G, Côté G. Validation of the French version of “Self Appraisal of Illness Questionnaire” [in French]. Rech Soins Infirm. 2009;97:74–84.CrossRefGoogle Scholar
  18. 18.
    Laliberté S, Lamoureux J, Sullivan MJ, et al. French translation of the Multidimensional Pain Inventory: L’inventaire multidimensionnel de la douleur. Pain Res Manag. 2008;13(6):497–505.CrossRefGoogle Scholar
  19. 19.
    Brenner K, Schmitz N, Pawliuk N, et al. Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample. Schizophr Res. 2007;95(1-3):86–95.CrossRefGoogle Scholar
  20. 20.
    Acquadro C, Lafortune L, Mear I. Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54. Health Qual Life Outcomes. 2003;1:70.CrossRefGoogle Scholar
  21. 21.
    Badia X, Webb SM, Prieto L, Lara N. Acromegaly Quality of Life Questionnaire (AcroQoL). Health Qual Life Outcomes. 2004;2:13.CrossRefGoogle Scholar
  22. 22.
    Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4:353–365.CrossRefGoogle Scholar
  23. 23.
    Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clini Drug Inv. 1996;11:278–288.CrossRefGoogle Scholar
  24. 24.
    Reilly MC, Lavin PT, Kahler KH, Pariser DM. Validation of the Dermatology Life Quality Index (DLQI) and the Work Productivity and Activity Impairment: Chronic Hand Dermatitis Questionnaire (WPAI-ChHD) in Chronic Hand Dermatitis (ChHD). J Am Academy Dermatol. 2003;48:128–130.CrossRefGoogle Scholar
  25. 25.
    Wahlqvist P, Carlsson J, Stålhammar N-O, Wiklund I. Validity of a Work Productivity and Activity Impairment Questionnaire for Patients with Symptoms of Gastro-Esophageal Reflux Disease (WPAI-GERD)—results from a cross-sectional study. Value in Health. 2002;5:106–113.CrossRefGoogle Scholar
  26. 26.
    Wahlqvist P, Guyatt G, Armstrong D, et al. Responsiveness to change and English language validation of the WPAI-GERD questionnaire—results from a Canadian study. Value in Health. 2004;7: A349.CrossRefGoogle Scholar
  27. 27.
    Kobelt G, Borgstrom F, Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. Br J Urol Int. 2003;9:190–195.CrossRefGoogle Scholar
  28. 28.
    Andréasson E, Svensson K, Berggren F. The validity of the work productivity and activity impairment questionnaire for patients with asthma (WPAI-asthma): results from a web-based study. Value in Health. 2003;6:780.CrossRefGoogle Scholar
  29. 29.
    Reilly MC, Bracco A, Ricci J-F, Santoro J, Stevens T. The validity and accuracy of the Work Productivity and Activity Impairment Questionnaire–Irritable Bowel Syndrome Version (WPAI: IBS). Alimentary Pharma & Therap. 2004;20:459–467.CrossRefGoogle Scholar
  30. 30.
    Jacobs RJ, Davidson JR, Gupta S, Meyerhoff AS. The effects of clonazepam on quality of life and work productivity in panic disorder. Am J Man Care. 1997;3:1187–1196.Google Scholar
  31. 31.
    Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once daily fexofenadine HCI improves quality of life and reduces work and activity impairment in patients with season allergic rhinitis. Ann Allergy Asthma Immunol. 1999;83:311–317.CrossRefGoogle Scholar
  32. 32.
    Tanner LA, Reilly M, Meltzer EO, Bradford JE, Mason J. Effect of fexofenadine HCI on quality of life and work, classroom and daily activity impairment in patients with seasonal allergic rhinitis. Am J Man Care. 1999;5(suppl): S235–S247.Google Scholar
  33. 33.
    Perrillo RP, Rothstein KD, Imperial JC, et al. Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C. J Viral Hepatitis. 2004;11:157–165.CrossRefGoogle Scholar
  34. 34.
    Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Alimentary Pharma & Therap. 2003;17:1309–1317.CrossRefGoogle Scholar
  35. 35.
    Wittchen HU, Beloch E. The impact of social phobia on quality of life. Int Clin Psychopharmacol. 1996;2(S3):15–23.CrossRefGoogle Scholar
  36. 36.
    Reilly Associates. WPAI: GH V2. https://doi.org/www.reillyassociates.net/WPAI_GH.html. Accessed February 16, 2010.
  37. 37.
    Gawlicki M. Procedures for Linguistic Validation of Health Status Questionnaires. Mansfield Center, CT: Corporate Translations Inc; 2004.Google Scholar
  38. 38.
    Public Health Agency of Canada. Work-Life Canada in the new millennium: a status report. https://doi.org/198.103.98.77/publicat/work-travail/report2/index-eng.php. Accessed August 5, 2010.Google Scholar
  39. 39.
    Davy D. Absenteeism costing companies $10b a year in lost productivity. The Hamilton Spectator. October 10, 2007.Google Scholar
  40. 40.
    Strong LL, Zimmerman FJ. Occupational injury and absence from work among African American, Hispanic and non-Hispanic white works in the National Longitudinal Survey of Youth. Am J Public Health. 2005;95(7):1226–1232.CrossRefGoogle Scholar
  41. 41.
    Broersen JP, de Zwart BC, van Dijk FJ, et al. Health complaints and working conditions experience in relation to work and age. Occup Environ Med. 1996;53(1):51–57.CrossRefGoogle Scholar
  42. 42.
    Milton N. Stress and absenteeism from work. https://doi.org/www.epistemics.co.uk/staff/nmilton/papers/stress.htm. Accessed August 5, 2010.
  43. 43.
    Goldberg M, Leclerc A, Bonenfant S, et al. Cohort profile: The GAZEL Cohort Study. Int J Epidemol. 2007;36(1):32–39.CrossRefGoogle Scholar
  44. 44.
    Gawlicki MC, Reilly MC, Popielnicki A, Reilly K. Linguistic validation of the US Spanish Work Productivity and Activity Impairment Questionnaire, general health version (WPAI: GH). Value in Health. 2006;9(3):199–204.CrossRefGoogle Scholar

Copyright information

© Drug Information Association, Inc 2012

Authors and Affiliations

  • Mary Gawlicki
    • 1
  • Shawn McKown
    • 1
  • Matthew Talbert
    • 1
  • Barbara Brandt
    • 1
  • Eric Bullington
    • 1
  1. 1.Corporate Translations IncChicagoUSA

Personalised recommendations